Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Safety Study to Evaluate the Long-term Effects of TAK-375 on Endocrine Function in Adult Subjects With Chronic Insomnia

NCT00656994 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00656994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00656994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Safety Study to Evaluate the Long-term Effects of TAK-375 on Endocrine Function in Adult Subjects With Chronic Insomnia
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
July 31, 2004
Enrollment
122 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia